Free Trial

Futura Medical (LON:FUM) Stock Crosses Below 200-Day Moving Average - Here's What Happened

Futura Medical logo with Medical background

Futura Medical plc (LON:FUM - Get Free Report) shares passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 34.50 ($0.42) and traded as low as GBX 31.10 ($0.38). Futura Medical shares last traded at GBX 31.83 ($0.39), with a volume of 416,493 shares traded.

Futura Medical Price Performance

The stock's fifty day simple moving average is GBX 32.86 and its 200-day simple moving average is GBX 34.47. The stock has a market cap of £96.28 million, a P/E ratio of -3,184.00 and a beta of 1.25.

Futura Medical Company Profile

(Get Free Report)

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.

Recommended Stories

Should You Invest $1,000 in Futura Medical Right Now?

Before you consider Futura Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Futura Medical wasn't on the list.

While Futura Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines